Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk of post-polypectomy bleeding with uninterrupted clopidogrel
2019-000996-17Phase 4Completed
- Sponsor
- Thomas Møller Jensen
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clopidogrel in postpolypectomy bleeding (PPB) (2 arms), sponsored by Thomas Møller Jensen. Primary endpoint: Clinically significant immediate post-polypectomy bleeding. Started Apr 2019; status: completed.
02
Drugs
clopidogrel
03
Conditions
postpolypectomy bleeding (PPB)
Beyond the preview
Go deeper on 2019-000996-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000996-17.